Ariel Wang
Medical Statistician
I work as a medical statistician in the Centre for Statistics in Medicine (CSM) since 2019. Before I join the CSM, I was doing my PhD in Health Science at the University of Warwick, Medical School. I also have an MSc in International Health Policy and Health Economics from LSE.
I am the trial statistician for the EMERALD, SPAARK, NEON, ATOMIC2, FUTURE-GB and IPI-GLIO clinical trials. I contribute to the randomisation monitoring, statistical analysis and reporting of trials across a range of clinical areas including diagnostic study, trauma, rehabilitation, surgical trials, as well as drug trials.
Recent publications
-
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study.
Journal article
Lois N. et al, (2021), Health technol assess, 25, 1 - 104
-
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): statistical analysis plan for a randomised controlled trial assessing the effectiveness of peri-articular liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone
Journal article
Wang A. et al, (2021), Trials
-
Study of Peri-Articular Anaesthetic for Replacement of the Knee (SPAARK): statistical analysis plan for a randomised controlled trial assessing the effectiveness of peri-articular liposomal bupivacaine plus bupivacaine hydrochloride compared with bupivacaine hydrochloride alone
Journal article
STOKES J. et al, (2021), Trials
-
A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 Trial
Journal article
HINKS T. et al, (2021), Lancet